SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2025-11-23 11:33
Tx date 2025-11-05 		$AGN
Algernon Health Inc. 		Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
Warrants
55 - Expiration of warrants
-5,496 vol 		280,000
Filed 2025-11-23 11:29
Tx date 2025-11-05 		$AGN
Algernon Health Inc. 		Kinley, James
5 - Senior Officer of Issuer
Holder: JFK Enterprises Ltd. (Indirect Ownership)
Subscription Rights Subscription Receipts
36 - Conversion or exchange 		$-30,000
-50,000 vol
$0.60 each 		0
Filed 2025-11-23 11:28
Tx date 2025-11-05 		$AGN
Algernon Health Inc. 		Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
Preferred Warrants
36 - Conversion or exchange
+25,000 vol 		25,000
Filed 2025-11-23 11:26
Tx date 2021-12-01 		$AGN
Algernon Health Inc. 		Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
Preferred Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2025-11-23 11:24
Tx date 2025-11-05 		$AGN
Algernon Health Inc. 		Kinley, James
5 - Senior Officer of Issuer
Holder: JFK Enterprises Ltd. (Indirect Ownership)
Preferred Shares Voting, convertible 1 for 10 common shares
36 - Conversion or exchange 		$30,000
+50,000 vol
$0.60 each 		50,000
Filed 2025-11-23 11:23
Tx date 2021-12-01 		$AGN
Algernon Health Inc. 		Kinley, James
5 - Senior Officer of Issuer
Holder: JFK Enterprises Ltd. (Indirect Ownership)
Preferred Shares Voting, convertible 1 for 10 common shares
00 - Opening Balance-Initial SEDI Report
Filed 2025-11-23 11:21
Tx date 2025-11-14 		$AGN
Algernon Health Inc. 		Kinley, James
5 - Senior Officer of Issuer
Holder: JFK Enterprises Ltd. (Indirect Ownership)
Warrants
16 - Acquisition or disposition under a prospectus exemption
+85,714 vol 		310,714
Filed 2025-11-23 11:19
Tx date 2025-11-14 		$AGN
Algernon Health Inc. 		Kinley, James
5 - Senior Officer of Issuer
Holder: JFK Enterprises Ltd. (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$11,999
+171,428 vol
$0.07 each 		1,416,428
Filed 2025-11-18 16:58
Tx date 2025-11-14 		$AGN
Algernon Health Inc. 		Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
16 - Acquisition or disposition under a prospectus exemption
+178,572 vol 		748,006
Filed 2025-11-18 16:52
Tx date 2025-11-14 		$AGN
Algernon Health Inc. 		Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$25,000
+357,144 vol
$0.07 each 		1,502,146
Filed 2025-08-05 16:22
Tx date 2025-07-24 		$AGN
Algernon Pharmaceuticals Inc. 		Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 7360232 MANITOBA LTD (Indirect Ownership)
Subscription Rights
16 - Acquisition or disposition under a prospectus exemption 		$60,000
+100,000 vol
$0.60 each 		100,000
Filed 2025-08-05 16:16
Tx date 2018-03-01 		$AGN
Algernon Pharmaceuticals Inc. 		Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 7360232 MANITOBA LTD (Indirect Ownership)
Subscription Rights
00 - Opening Balance-Initial SEDI Report
Filed 2025-07-29 12:28
Tx date 2025-07-24 		$AGN
Algernon Pharmaceuticals Inc. 		Kinley, James
5 - Senior Officer of Issuer
Holder: JFK Enterprises Ltd. (Control or Direction)
Subscription Rights Subscription Receipts
16 - Acquisition or disposition under a prospectus exemption 		$30,000
+50,000 vol
$0.60 each 		50,000
Filed 2025-07-29 12:24
Tx date 2021-12-01 		$AGN
Algernon Pharmaceuticals Inc. 		Kinley, James
5 - Senior Officer of Issuer
Holder: JFK Enterprises Ltd. (Control or Direction)
Subscription Rights Subscription Receipts
00 - Opening Balance-Initial SEDI Report
Filed 2025-03-28 22:07
Tx date 2025-03-27 		$AGN
Algernon Pharmaceuticals Inc. 		Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$450.00
+5,000 vol
$0.09 each 		1,145,002
Filed 2025-03-28 22:07
Tx date 2025-03-26 		$AGN
Algernon Pharmaceuticals Inc. 		Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$150.00
+2,000 vol
$0.075 each 		1,140,002
Filed 2025-03-25 22:54
Tx date 2025-03-25 		$AGN
Algernon Pharmaceuticals Inc. 		Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 7360232 MANITOBA LTD (Indirect Ownership)
Common Shares
47 - Acquisition or disposition by gift
-500,000 vol 		623,000
Filed 2025-03-25 22:36
Tx date 2025-03-20 		$AGN
Algernon Pharmaceuticals Inc. 		Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 7360232 MANITOBA LTD (Indirect Ownership)
Common Shares
57 - Exercise of rights
+700,000 vol 		1,123,000
Filed 2025-03-25 12:33
Tx date 2023-03-13 		$AGN
Algernon Pharmaceuticals Inc. 		Kinley, James
5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation 		$41,512
+40,500 vol
$1.02 each 		94,000
Filed 2025-03-25 12:24
Tx date 2025-03-20 		$AGN
Algernon Pharmaceuticals Inc. 		Kinley, James
5 - Senior Officer of Issuer
Holder: JFK Enterprises Ltd. (Indirect Ownership)
Common Shares
57 - Exercise of rights
+500,000 vol 		1,245,000